Antinuclear antibodies (ANA) are autoantibodies and occur in patients with a variety of autoimmune diseases, both systemic and organ-specific.
ANA is a screening test for patients suspected of having a systemic rheumatic disease, also referred to as connective tissue disease.
There is an additional £15 phlebotomy fee.
